Does Probiotic Supplementation Prevent Kidney Injury During Strenuous Physical Exercise?

Not Applicable

Completed

• Conditions: Kidney Injury; Heat Stress
• Interventions: Dietary Supplement: Placebo; Dietary Supplement: Probiotic, Lactobacillus

• Registration Number: NCT04985292
• Lead Sponsor: Göteborg University

Brief Summary

Severe heat strain arising from intense physical work under climate conditions that does not allow sufficient heat dissipation may lead to heat stroke. This severe conditions is hypothesized to be secondary to increased gut permeability and leakage of bacterial toxins across the gut membrane, stimulating a systematic inflammatory response and associated organ injury. Repeated such sub-clinical increases in gut permeability has been suggested to contribute to the high burden of chronic kidney disease among heat-stressed workers. Many marathon runners experience a transient increase in kidney injury biomarkers while running. Probiotics have been studied as a way to decrease gut permeability and reduce systemic inflammation in many settings, including in athletes . However, no study has measured renal outcomes among workers or athletes performing strenuous activity. This is of interest as it could test the hypothesis that gut-induced inflammation is a driver of kidney injury during heat stress, and could point to a possible intervention to add on to efforts to relieve heat strain.

In the present study, recreational or professional runners will be randomized to take a probiotic supplement or placebo during a 4 week period preceding a strenuous physical exercise (minimum 21 km run). Urine samples will be taken before and after the run, and analyzed for markers of renal injury and inflammation.

Detailed Description

Participants registered to run in organised half-marathons, marathons and ultramarathons in Southern Sweden will be recruited. They will be asked to abstain from probiotic supplementation (including functional foods with probiotics) for 2 weeks, and then commence a 4-week period of probiotic or placebo supplementation.

At the end of the 4 week treatment period, the participants run the race. Urine samples are taken before and after the race and analysed for kidney injury markers.

Stool samples are taken by participants at the initiation of the treatment period, last stool before the race, and first stool after the race.

Study Timeline

• Study First Submitted: 2021-06-10
• Study First Submitted QC: 2021-07-30
• Study First Posted: 2021-08-02
• Study Start: 2021-09-01
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-15
• Last Update Posted: 2024-04-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

• Planning to run one of the long-distance races included.

Exclusion Criteria

• Not having run at least 21 km previously,
• smoking,
• living too far away from the study area,
• unwilling to abstain from probiotic supplementation during treatment period,
• unwilling to abstain from NSAIDs or gut-permeability lowering supplements before the run,
• regular use of prescribed drugs (including hormonal contraceptives).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	Placebo	Inactive substance packaged to be identical to active treatment
Probiotic	Probiotic, Lactobacillus	10\^10 colony-forming units of a Lactobacillus strain, packaged in a capsule, once daily

Primary Outcome Measures

Name	Time	Method
Urine tubular kidney injury marker (Kidney Injury Molecule 1 (KIM-1), monocyte chemotactic protein 1 (MCP-1), Insulin Growth Factor Binding Protein 7 (IGFBP-7)) composite variable aggregated using structural equations modelling.	From before the run to after the run (estimated run times 2-24 hours), morning urine after run, and 24 hours after the run finish. These time point are combined to one main outcome by calculating the area under the curve.	Tubular injury markers measured in urine (e.g. KIM-1, MCP-1, IGFBP-7) combined using structural equations modelling and then combined over the 24 hour post-run period by calculating the area under the curve of this composite outcome variable in the 24 hours after the run. Exact list of markers to be determined based on budget available after sample collection is completed.

Trial Locations

Locations (1)

Occupational and Environmental Medicine; 🇸🇪 Gothenburg, Sweden